The estimated Net Worth of Clifford D Nastas is at least $281 Tausend dollars as of 19 November 2018. Mr. Nastas owns over 9,000 units of Invacare stock worth over $25,902 and over the last 10 years he sold IVC stock worth over $0. In addition, he makes $255,270 as Independent Director at Invacare.
Clifford has made over 3 trades of the Invacare stock since 2016, according to the Form 4 filled with the SEC. Most recently he bought 9,000 units of IVC stock worth $48,780 on 19 November 2018.
The largest trade he's ever made was buying 9,000 units of Invacare stock on 19 November 2018 worth over $48,780. On average, Clifford trades about 1,583 units every 77 days since 2015. As of 19 November 2018 he still owns at least 39,246 units of Invacare stock.
You can see the complete history of Mr. Nastas stock trades at the bottom of the page.
Clifford D. Nastas serves as Independent Director of the Company. Mr. Nastas served as President and Chief Executive Officer of Radiac Abrasives Company, a manufacturer of conventional bonded and super abrasives in North America from January 2016 until December 2018. Since 2014, Mr. Nastas has been a Director of Dan T. Moore Company, Inc., a holding company of diverse advanced materials manufacturing and technology businesses and became co-chairman in 2016. Also since 2014, Mr. Nastas has served as a Director of Shorr Packaging Corporation, an ESOP-owned company that distributes packaging supplies throughout North America. Mr. Nastas served as Chief Executive Officer and a Director of Material Sciences Corporation (formerly, Nasdaq: MASC), Elk Grove Village, Illinois, a publicly traded diversified industrial manufacturing company providing high-value coated metal, acoustical and lightweight composite solutions from 2005 until the company was sold in March 2014. From 2001 to 2005, Mr. Nastas served in various capacities at Material Sciences, including as President and Chief Operating Officer. Prior to joining Material Sciences, Mr. Nastas served in various general management, sales, and manufacturing capacities with Honeywell International, formerly Allied Signal (NYSE: HON), Morris Township, New Jersey, Avery Dennison Corporation (NYSE: AVY), Glendale, California, and Ford Motor Company (NYSE: F), Dearborn, Michigan.
As the Independent Director of Invacare, the total compensation of Clifford Nastas at Invacare is $255,270. There are 10 executives at Invacare getting paid more, with Matthew Monaghan having the highest compensation of $8,340,920.
Clifford Nastas is 57, he's been the Independent Director of Invacare since 2015. There are 7 older and 9 younger executives at Invacare. The oldest executive at Invacare Corp. is Susan Alexander, 63, who is the Independent Director.
Clifford's mailing address filed with the SEC is ONE INVACARE WAY, , ELYRIA, OH, 44035.
Over the last 21 years, insiders at Invacare have traded over $3,551,958 worth of Invacare stock and bought 391,450 units worth $2,325,949 . The most active insiders traders include Edward F Crawford, Aaron Malachi Iii Mixon und Steven H Azurite Management.... On average, Invacare executives and independent directors trade stock every 52 days with the average trade being worth of $10,700. The most recent stock trade was executed by Steven H Azurite Management... on 17 November 2022, trading 122,820 units of IVC stock currently worth $47,900.
Invacare Corporation is a leading manufacturer and distributor in its markets for medical equipment used in non-acute care settings. At its core, the Company designs, manufactures, and distributes medical devices that help people to move, breathe, rest and perform essential hygiene. The Company provides clinically complex medical device solutions for congenital (e.g., cerebral palsy, muscular dystrophy, spina bifida), acquired (e.g., stroke, spinal cord injury, traumatic brain injury, post-acute recovery, pressure ulcers) and degenerative (e.g., ALS, multiple sclerosis, chronic obstructive pulmonary disease (COPD), elderly, bariatric) ailments. The Company's products are important parts of care for people with a wide range of challenges, from those who are active and involved in work or school each day and may need additional mobility or respiratory support, to those who are cared for in residential care settings, at home and in rehabilitation centers. The Company sells its products principally to home medical equipment providers with retail and e-commerce channels, residential care operators, distributors and government health services in North America, Europe and Asia Pacific.
Invacare executives and other stock owners filed with the SEC include: